Question 1

What is Molina Healthcare's P/B ratio?

Accepted Answer

Molina Healthcare (MOH) P/B ratio is 2.7× as of July 22, 2026. The ratio is calculated by dividing market capitalisation by book value of equity, using USD-normalised financials (IAS 21 exchange-rate translation for non-USD reporters).

Question 2

How is the P/B ratio calculated?

Accepted Answer

P/B = Market Capitalisation ÷ Book Value of Equity (most recent quarterly shareholders' equity), or equivalently Share Price ÷ Book Value Per Share. All inputs are sourced from audited GAAP/IFRS filings and translated to USD using period-end exchange rates so the multiple is comparable across companies and currencies.

Question 3

What is the P/B ratio?

Accepted Answer

The price-to-book (P/B) ratio compares a company's market capitalisation to its book value of equity (total shareholders' equity) on the most recent quarterly balance sheet. It is calculated as market cap ÷ book value of equity (equivalent to share price ÷ book value per share). A P/B below 1× implies the market values the business below its accounting net worth; values well above 1× reflect intangible assets, brand value, or a high return on equity.

Question 4

What is a good P/B ratio for Molina Healthcare?

Accepted Answer

A "good" P/B depends on the business model. Banks, insurers, and other capital-heavy financials typically trade near 1×; asset-light technology and consumer-brand companies can sustainably trade at 5×+ because much of their value is intangible. P/B is most informative when paired with return on equity (ROE). For Molina Healthcare specifically, the relevant sector benchmark is the current sector median of 3.2×.

Question 5

Is Molina Healthcare's P/B ratio high or low?

Accepted Answer

Molina Healthcare's P/B ratio of 2.7× is below its own 5-year average of 4.7× and below the sector median of 3.2×. That places the current reading at the 19th percentile of its 10-year history. A higher multiple usually reflects stronger expected growth, lower perceived risk, or higher returns on capital; a lower multiple reflects the opposite.

Question 6

What is Molina Healthcare's historical P/B ratio range?

Accepted Answer

In the available daily series, Molina Healthcare (MOH) P/B ratio has ranged from a low of 0.9× in 2008 to a high of 7.8× in 2022. The 5-year average is 4.7× and the 5-year median is 4.8×.

Question 7

What was Molina Healthcare's P/B ratio in 2025?

Accepted Answer

Molina Healthcare (MOH) P/B ratio at the end of 2025 was 2.2×. Annual values reflect the multiple on the last trading day of each calendar year, using the trailing twelve-month book value figure available at that date.

Question 8

Why does Molina Healthcare's P/B ratio change over time?

Accepted Answer

Valuation multiples move with two inputs: the numerator (market capitalisation, which tracks the share price) and the denominator (book value). Share-price changes — driven by interest rates, earnings expectations, risk appetite, and broader market sentiment — typically dominate short-term moves, while changes in the underlying fundamental drive the longer-term trend. As a result, the ratio can rise during stock-price rallies even if the business itself has not become more valuable, and fall during sell-offs even when fundamentals are improving.


2025	$8.81B	$4.07B	2.2×	-1.5×	Dec 31, 2025
2024	$16.7B	$4.5B	3.7×	-1.3×	Dec 31, 2024
2023	$21B	$4.22B	5.0×	-1.5×	Dec 31, 2023
2022	$19.2B	$2.96B	6.5×	-0.6×	Dec 31, 2022
2021	$18.4B	$2.63B	7.0×	+1.0×	Dec 31, 2021
2020	$12.6B	$2.1B	6.0×	+1.7×	Dec 31, 2020
2019	$8.41B	$1.96B	4.3×	-0.1×	Dec 31, 2019
2018	$7.21B	$1.65B	4.4×	+1.1×	Dec 31, 2018
2017	$4.38B	$1.34B	3.3×	+1.5×	Dec 31, 2017
2016	$3B	$1.65B	1.8×	-0.3×	Dec 31, 2016
2015	$3.37B	$1.56B	2.2×	-0.4×	Dec 31, 2015
2014	$2.62B	$1.01B	2.6×	+0.8×	Dec 31, 2014
2013	$1.59B	$893M	1.8×	+0.2×	Dec 31, 2013
2012	$1.26B	$782M	1.6×	+0.3×	Dec 31, 2012
2011	$1.03B	$755M	1.4×	+0.2×	Dec 31, 2011
2010	$843M	$719M	1.2×	+0.1×	Dec 31, 2010
2009	$584M	$543M	1.1×	+0.2×	Dec 31, 2009
2008	$467M	$532M	0.9×	-1.4×	Dec 31, 2008
2007	$1.1B	$490M	2.2×	+0.1×	Dec 31, 2007
2006	$912M	$420M	2.2×	+0.1×	Dec 31, 2006
2005	$740M	$363M	2.0×	-1.8×	Dec 31, 2005
2004	$1.28B	$331M	3.9×	+1.0×	Dec 31, 2004
2003	$638M	$221M	2.9×	—	Dec 31, 2003


Charles River (CRL)	2.6×
Danaher (DHR)	2.6×
Spruce Biosciences (SPRB)	2.6×
Regeneron Pharmaceuticals (REGN)	2.6×
Henry Schein (HSIC)	2.5×
Labcorp Holdings (LH)	2.5×
Solventum (SOLV)	2.3×
Medtronic (MDT)	2.2×
Elevance Health (ELV)	1.9×
Becton, Dickinson and (BDX)	1.8×
Pfizer (PFE)	1.8×
Cigna (CI)	1.7×
Waters Corporation (WAT)	1.6×
Cooper Companies (COO)	1.5×
Universal Health Services (UHS)	1.5×
Biogen (BIIB)	1.4×
Baxter International (BAX)	1.4×
Zimmer Biomet Holdings (ZBH)	1.4×
Revvity (RVTY)	1.4×
CVS Health (CVS)	1.2×
Humana (HUM)	1.1×
Viatris (VTRS)	1.1×
Ovid Therapeutics (OVID)	0.8×
Centene (CNC)	0.8×
Teladoc Health (TDOC)	0.7×

P/B Ratio for Molina Healthcare (MOH) 2003-2026

P/B Ratio daily chart for Molina Healthcare (MOH)

Historical P/B Ratio for Molina Healthcare (MOH) from 2003 to 2025

About P/B Ratio at Molina Healthcare (MOH)

Molina Healthcare P/B Ratio by Year

Molina Healthcare P/B Ratio 2025: 2.2×

Molina Healthcare P/B Ratio 2024: 3.7×

Molina Healthcare P/B Ratio 2023: 5.0×

Molina Healthcare P/B Ratio 2022: 6.5×

Molina Healthcare P/B Ratio 2021: 7.0×

Sector peers by P/B Ratio — chart

Sector peers by P/B Ratio — table

Frequently asked questions

Molina Healthcare (MOH) Key Financials